Artur Ślesik

Artur Ślesik is a technology and financial markets journalist at Bez-kabli.pl, covering artificial intelligence, semiconductors, technology stocks and emerging innovations. A graduate of Warsaw University of Technology, he combines a technical background with market analysis to explain how new technologies are shaping industries, businesses and investment trends worldwide.

CSL shares rebound after neffy nasal spray approval as buyback rolls on

CSL shares rebound after neffy nasal spray approval as buyback rolls on

Sydney, February 16, 2026, 17:01 AEDT — The session has ended. CSL Ltd picked up 1.4% by Monday’s close, recouping a slice of last week’s drop. The move followed news that its Seqirus arm secured Australian approval for the neffy adrenaline nasal spray, alongside a fresh update on the company’s share buyback. Shares wrapped up at A$152.17, though that’s still roughly 15.6% below where they stood five sessions ago.
February 16, 2026
1 52 53 54 55 56 80